These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Does VEGF represent a potential treatment for amyotrophic lateral sclerosis?
    Author: Iłzecka J.
    Journal: Curr Opin Investig Drugs; 2006 Jan; 7(1):54-9. PubMed ID: 16425672.
    Abstract:
    Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease. The pathogenesis of ALS is unclear and there is no effective treatment. Vascular endothelial growth factor (VEGF) is a cytokine that has a protective function via angiogenic, neurotrophic, gliotrophic and anti-apoptotic activity. Data indicate that VEGF can inhibit neurodegeneration in ALS and may have therapeutic potential in this disease. The use of gene therapy to deliver VEGF into the central nervous system is being evaluated.
    [Abstract] [Full Text] [Related] [New Search]